We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Completes BLA Submission for COVID-19 Vaccine
Moderna Completes BLA Submission for COVID-19 Vaccine
Moderna said it has completed submitting data for its COVID-19 vaccine’s rolling biologics license application (BLA) and has requested an FDA Priority Review, which would require the FDA to make its decision within 60 days.